Tumor Tissue Explant Culture of Patient-Derived Xenograft as Potential Prioritization Tool for Targeted Therapy

Despite of remarkable progress made in the head and neck cancer (HNC) therapy, the survival rate of this metastatic disease remain low. Tailoring the appropriate therapy to patients is a major challenge and highlights the unmet need to have a good preclinical model that will predict clinical respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Susmita, Prasad, Manu, Kundu, Kiran, Cohen, Limor, Yegodayev, Ksenia M., Zorea, Jonathan, Joshua, Ben-Zion, Lasry, Batel, Dimitstein, Orr, Bahat-Dinur, Anat, Mizrachi, Aviram, Lazar, Vladimir, Elkabets, Moshe, Porgador, Angel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350270/
https://www.ncbi.nlm.nih.gov/pubmed/30723707
http://dx.doi.org/10.3389/fonc.2019.00017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350270/
https://www.ncbi.nlm.nih.gov/pubmed/30723707
http://dx.doi.org/10.3389/fonc.2019.00017

Ejemplares similares